Powder: -20°C for 3 years | In solvent: -80°C for 1 year
SL-01 is an oral derivative of gemcitabine. SL-01 inhibited human breast cancer growth through the induction of apoptosis. SL-01 inhibited human cancer growth more potently than gemcitabine.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
250 mg | 35 days | $ 93.00 | |
500 mg | 35 days | $ 170.00 | |
1 g | 35 days | $ 233.00 |
Description | SL-01 is an oral derivative of gemcitabine. SL-01 inhibited human breast cancer growth through the induction of apoptosis. SL-01 inhibited human cancer growth more potently than gemcitabine. |
Synonyms | Z L Phe chloromethyl ketone, NSC-251810, ZLPhe chloromethyl ketone, Z-Phe-chloromethylketone |
Molecular Weight | 331.79 |
Formula | C18H18ClNO3 |
CAS No. | 26049-94-5 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: Soluble
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
SL-01 26049-94-5 NSC251810 Z L Phe chloromethyl ketone NSC-251810 SL01 SL 01 NSC 251810 ZLPhe chloromethyl ketone Z-Phe-chloromethylketone inhibitor inhibit